NewAmsterdam Pharma Co N.V. (NAMS) Insider Trading

Name: NewAmsterdam Pharma Co N.V. (NAMS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Kastelein Johannes Jacob Pieter (Chief Scientific Officer): Exercise/Conversion of 50,246 shares.

Get alerted when insiders trade NAMS

Email address

Loading company data...

Loading company details...